6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Reports Fourth Quarter and Full Year 2025 Financial Results
Announces Name Change to Filana Therapeutics, Inc.
Announces Closure of U.S. Department of Justice Investigation
Entry into a Material Definitive Agreement
Amended material disclosure
Other Events
CEO Richard J. Barry Receives $355,000 Bonus; CFO Eric J. Schoen $215,000
FY 2025
Q3
Q2
Q1
FY 2024
Effectiveness Notice
Prospectus Filed Pursuant to Rule 424(b)(2)
Registration Statement for Securities Offered under a Shelf Registration
Registration of Securities
Certificate
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Registration of Securities under Section 12(g)
Submission Upload
Correspondence